Clinical Impact and Safety of Non-Target Punctures (NTP) during Portal Vein Access in TIPS Procedure.

angiography cirrhosis complications non-target puncture portal hypertension portal vein portal vein access refractory ascites transjugular intrahepatic portosystemic shunt (TIPS) variceal bleeding

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
03 Jun 2023
Historique:
received: 18 04 2023
revised: 31 05 2023
accepted: 31 05 2023
medline: 28 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Although non-target puncture (NPT)-related complications are well known to clinicians performing TIPS, there is no NTP-focused study to assess the true clinical sequalae of NTP-related complications. In this study, the aim was to evaluate the incidence, safety, clinical outcomes and complications related to NTPs during the portal access of TIPS procedures. A retrospective review of 369 TIPS procedures from October 2007 to September 2019 was performed. We identified inadvertent NTPs, including biliary, hepatic artery, lymphatic and capsular punctures. Next, the medical records and images were reviewed and analyzed to assess the safety and clinical outcomes of these cohorts. A total of 71 NTPs were identified in 56 patients (15.18% of 369 patients). Of 369 TIPS patients, there were (1) 28 biliary punctures (7.6%), (2) 16 extracapsular punctures (4.3%), (3) 15 lymphatic punctures (4.1%) and (4) 12 hepatic artery punctures (3.3%). The overall complication rate was 2.2% (8/369). Based on the Clavien-Dindo classification, three patients (0.8%) had a minor complication. In addition, five patients (1.4%) experienced grade II-V major complications, such as symptomatic hemoperitoneum, arterio-biliary fistula or hemorrhagic shock leading to death. Mortality (0.5%) was only caused by extracapsular puncture combined with other NTP. NTPs during the portal access of TIPS procedures are associated with low complication risk. However, when extracapsular punctures are combined with other NTPs, a more severe complication, including mortality, can occur. Nevertheless, all patients with NTP should be closely monitored at a higher level of care after TIPS placement.

Sections du résumé

BACKGROUND BACKGROUND
Although non-target puncture (NPT)-related complications are well known to clinicians performing TIPS, there is no NTP-focused study to assess the true clinical sequalae of NTP-related complications. In this study, the aim was to evaluate the incidence, safety, clinical outcomes and complications related to NTPs during the portal access of TIPS procedures.
METHODS METHODS
A retrospective review of 369 TIPS procedures from October 2007 to September 2019 was performed. We identified inadvertent NTPs, including biliary, hepatic artery, lymphatic and capsular punctures. Next, the medical records and images were reviewed and analyzed to assess the safety and clinical outcomes of these cohorts.
RESULTS RESULTS
A total of 71 NTPs were identified in 56 patients (15.18% of 369 patients). Of 369 TIPS patients, there were (1) 28 biliary punctures (7.6%), (2) 16 extracapsular punctures (4.3%), (3) 15 lymphatic punctures (4.1%) and (4) 12 hepatic artery punctures (3.3%). The overall complication rate was 2.2% (8/369). Based on the Clavien-Dindo classification, three patients (0.8%) had a minor complication. In addition, five patients (1.4%) experienced grade II-V major complications, such as symptomatic hemoperitoneum, arterio-biliary fistula or hemorrhagic shock leading to death. Mortality (0.5%) was only caused by extracapsular puncture combined with other NTP.
CONCLUSIONS CONCLUSIONS
NTPs during the portal access of TIPS procedures are associated with low complication risk. However, when extracapsular punctures are combined with other NTPs, a more severe complication, including mortality, can occur. Nevertheless, all patients with NTP should be closely monitored at a higher level of care after TIPS placement.

Identifiants

pubmed: 37371725
pii: biomedicines11061630
doi: 10.3390/biomedicines11061630
pmc: PMC10295835
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Vasc Interv Radiol. 2012 Dec;23(12):1594-602
pubmed: 23099001
Diagn Interv Imaging. 2019 Jul - Aug;100(7-8):445-453
pubmed: 30711496
Eur J Gastroenterol Hepatol. 2004 Jan;16(1):9-18
pubmed: 15095847
AJR Am J Roentgenol. 2011 Mar;196(3):675-85
pubmed: 21343513
Tech Vasc Interv Radiol. 2008 Dec;11(4):217-24
pubmed: 19527848
J Vasc Interv Radiol. 2005 Feb;16(2 Pt 1):227-34
pubmed: 15713923
World J Surg. 2001 Mar;25(3):337-45; discussion 345-6
pubmed: 11343189
J Magn Reson Imaging. 1994 Mar-Apr;4(2):145-50
pubmed: 8180452
J Clin Med. 2012 Oct 10;1(1):15-21
pubmed: 26237567
Am J Gastroenterol. 1998 Oct;93(10):1952-5
pubmed: 9772063
Radiology. 1990 Mar;174(3 Pt 2):1027-30
pubmed: 2305084
J Vasc Interv Radiol. 2017 Oct;28(10):1432-1437.e3
pubmed: 28757285
N Engl J Med. 1994 Jan 20;330(3):165-71
pubmed: 8264738
Hepatology. 2010 Jan;51(1):306
pubmed: 19902484
Cardiovasc Intervent Radiol. 2001 Jan-Feb;24(1):64-7
pubmed: 11178717
AJR Am J Roentgenol. 2017 Jan;208(1):W11-W16
pubmed: 27786554
Semin Liver Dis. 1999;19(4):457-73
pubmed: 10643629
J Vasc Interv Radiol. 1996 Jan-Feb;7(1):143-6
pubmed: 8773990
Radiology. 1993 Jul;188(1):85-8
pubmed: 8511322
Gastroenterology. 1996 Nov;111(5):1353-7
pubmed: 8898650
Radiology. 1994 Jun;191(3):705-12
pubmed: 8184050
Cardiovasc Intervent Radiol. 2012 Dec;35(6):1295-300
pubmed: 23070105
J Vasc Interv Radiol. 2005 May;16(5):615-29
pubmed: 15872315
Diagn Interv Imaging. 2016 Jun;97(6):673-5
pubmed: 26947722
Radiographics. 2008 Mar-Apr;28(2):359-78
pubmed: 18349445
J Vasc Interv Radiol. 2006 Nov;17(11 Pt 1):1771-9
pubmed: 17142707
Cardiovasc Intervent Radiol. 2002 May-Jun;25(3):171-5
pubmed: 12058211
Diagn Interv Imaging. 2016 Nov;97(11):1095-1102
pubmed: 27503116
Diagn Interv Imaging. 2015 Jul-Aug;96(7-8):745-55
pubmed: 26094039
J Hepatol. 2013 Nov;59(5):1081-93
pubmed: 23811307
Diagn Interv Imaging. 2015 Apr;96(4):357-63
pubmed: 25540929
J Vasc Interv Radiol. 2016 Aug;27(8):1148-53
pubmed: 27052948
Radiographics. 1993 Nov;13(6):1185-210
pubmed: 8290720
Gut. 2000 Jun;46(6):856-60
pubmed: 10807900
Aliment Pharmacol Ther. 2016 Nov;44(10):1051-1061
pubmed: 27670147
Cardiovasc Intervent Radiol. 1999 Mar-Apr;22(2):150-1
pubmed: 10094998
Z Gastroenterol. 1995 May;33(5):255-9
pubmed: 7610693

Auteurs

Sasikorn Feinggumloon (S)

Division of Interventional Radiology, Department of Radiology, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Zachary Haber (Z)

Division of Interventional Radiology, Department of Radiology, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Sammy Saab (S)

Division of Hepatology, Department of Medicine, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Fady Kaldas (F)

Division of Liver and Pancreas Transplantation Surgery, Department of Surgery, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Navid Eghbalieh (N)

Division of Interventional Radiology, Department of Radiology, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Thanh T Luong (TT)

Division of Interventional Radiology, Department of Radiology, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Justin P McWilliams (JP)

Division of Interventional Radiology, Department of Radiology, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Edward Wolfgang Lee (EW)

Division of Interventional Radiology, Department of Radiology, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Division of Liver and Pancreas Transplantation Surgery, Department of Surgery, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

Classifications MeSH